1887
Skip to content
Research Open Access
Like 0

Abstract

BACKGROUND

Congenital syphilis is a potentially serious, but preventable infection. Several European countries have recently reported increasing trends.

AIM

This study assessed national incidence and temporal trends of congenital syphilis and prevalence of pregnancies with active syphilis in Denmark between 2010 and 2024.

METHODS

Using nationwide individual-level data linked through civil registration numbers across Danish health and population registers, we identified all maternal and congenital syphilis cases among live-born children born in Denmark from 2010 to 2024. We calculated annual incidence per 10,000 live births and analysed temporal trends and annual percent change (APC) with 95% confidence intervals (CI), using Poisson or negative binomial regression models.

RESULTS

Five infants with confirmed congenital syphilis were recorded among 894,345 live births, corresponding to an incidence of 0.6 per 100,000 (95% CI: 0.2–1.4). No infants with congenital syphilis were identified after 2016. For each infant, a plausible explanation for screening failure was identified: two women arrived in Denmark late in pregnancy, two were infected late in pregnancy. None of these events reflected failure of the first-trimester screening algorithm itself. One event was due to a reporting irregularity. Poisson regression showed a decreasing trend (APC = −21.7%; 95% CI: −43.4 to −1.0). Active syphilis infection occurred in 172 pregnancies, amounting to 20.0 per 100,000 live births (95% CI: 17.2–23.2) with no temporal changes.

CONCLUSIONS

Congenital syphilis is now eliminated in Denmark. The incidence of pregnancies with active syphilis infection remained stable despite increasing syphilis prevalence in the general population, confirming the continued effectiveness of the Danish national antenatal syphilis screening programme.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2026.31.35.2600031
2026-09-03
2026-10-14
/content/10.2807/1560-7917.ES.2026.31.35.2600031
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/31/35/eurosurv-31-35-5.html?itemId=/content/10.2807/1560-7917.ES.2026.31.35.2600031&mimeType=html&fmt=ahah

References

  1. Sankaran D, Partridge E, Lakshminrusimha S. Congenital Syphilis-an illustrative review. Children (Basel). 2023;10(8):1310.  https://doi.org/10.3390/children10081310  PMID: 37628309 
  2. Gomez GB, Kamb ML, Newman LM, Mark J, Broutet N, Hawkes SJ. Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis. Bull World Health Organ. 2013;91(3):217-26.  https://doi.org/10.2471/BLT.12.107623  PMID: 23476094 
  3. Alexander JM, Sheffield JS, Sanchez PJ, Mayfield J, Wendel GD Jr. Efficacy of treatment for syphilis in pregnancy. Obstet Gynecol. 1999;93(1):5-8.  https://doi.org/10.1016/S0029-7844(98)00338-X  PMID: 9916946 
  4. World Health Organization (WHO). Global guidance on criteria and processes for validation- elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus. Geneva: WHO; 4 Aug 2022. Available from: https://www.who.int/publications/i/item/9789240039360
  5. Salomè S, Cambriglia MD, Montesano G, Capasso L, Raimondi F. Congenital Syphilis: a re-emerging but preventable infection. Pathogens. 2024;13(6):481.  https://doi.org/10.3390/pathogens13060481  PMID: 38921779 
  6. World Health Organization (WHO). The global elimination of congenital syphilis: rationale and strategy for action. Geneva: WHO; 4 Sep 2007. Available from: https://www.who.int/publications/i/item/9789241595858
  7. McDonald R, O’Callaghan K, Torrone E, Barbee L, Grey J, Jackson D, et al. Vital Signs: missed opportunities for preventing congenital syphilis - United States, 2022. MMWR Morb Mortal Wkly Rep. 2023;72(46):1269-74.  https://doi.org/10.15585/mmwr.mm7246e1  PMID: 37971936 
  8. European Centre for Disease Prevention and Control (ECDC). Congenital syphilis. In: ECDC. Annual epidemiological report for 2023. Stockholm: ECDC; 10 Feb 2025. Available from: https://www.ecdc.europa.eu/en/publications-data/congenital-syphilis-annual-epidemiological-report-2023
  9. David A, Posfay-Barbe KM, Aguiar Nogueira C, Toutous Trellu L. Congenital syphilis in Switzerland: a marker of inequality? A mini-review. Front Public Health. 2023;11:1265725.  https://doi.org/10.3389/fpubh.2023.1265725  PMID: 37780442 
  10. Salomè S, Cambriglia MD, Scarano SM, Capone E, Betts I, Pacella D, et al. Congenital syphilis in the twenty-first century: an area-based study. Eur J Pediatr. 2023;182(1):41-51.  https://doi.org/10.1007/s00431-022-04703-5  PMID: 36376519 
  11. Moseley P, Bamford A, Eisen S, Lyall H, Kingston M, Thorne C, et al. Resurgence of congenital syphilis: new strategies against an old foe. Lancet Infect Dis. 2024;24(1):e24-35.  https://doi.org/10.1016/S1473-3099(23)00314-6  PMID: 37604180 
  12. European Centre for Disease Prevention and Control (ECDC). Antenatal screening for HIV, hepatitis B, syphilis and rubella susceptibility in the EU/EEA. Stockholm: ECDC; 30 Mar 2016. Available from: https://www.ecdc.europa.eu/en/publications-data/antenatal-screening-hiv-hepatitis-b-syphilis-and-rubella-susceptibility-eueea
  13. Statens Serum Institut (SSI). Pregnancy screening 2023. Copenhagen: SSI; 24 Oct 2024. Available from: https://en.ssi.dk/surveillance-and-preparedness/surveillance-in-denmark/annual-reports-on-disease-incidence/p/pregnancy-screening-2023
  14. Statens Serum Institut (SSI). Mandatory notification systems. Copenhagen: SSI; 21 Mar 2016. Available from: https://en.ssi.dk/surveillance-and-preparedness/surveillance-in-denmark/mandatory-notification-systems
  15. European Commission (EC). Commission implementing decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions. Brussels: EC; 22 Jun 2018. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32018D0945&from=EN#page=43
  16. World Health Organization (WHO). Global guidance on criteria and processes for validation- elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus. Geneva: WHO; 4 Aug 2022. Available from: https://www.who.int/publications/i/item/9789240039360
  17. World Health Organization Regional Office for Europe (WHO/Europe). Regional action plans for ending AIDS and the epidemics of viral hepatitis and sexually transmitted infections 2022-2030. Copenhagen: WHO/Europe; 2023. Available from: https://iris.who.int/handle/10665/369243
  18. World Health Organization (WHO). Denmark becomes first country in the European Union to eliminate mother-to-child transmission of HIV and syphilis. Geneva: WHO; 27 Feb 2026. Available from: https://www.who.int/news/item/27-02-2026-denmark-becomes-first-country-in-the-european-union-to-eliminate-of-mother-to-child-transmission-of-hiv-and-syphilis
  19. Taylor M, Newman L, Ishikawa N, Laverty M, Hayashi C, Ghidinelli M, et al. Elimination of mother-to-child transmission of HIV and syphilis (EMTCT): Process, progress, and program integration. PLoS Med. 2017;14(6):e1002329.  https://doi.org/10.1371/journal.pmed.1002329  PMID: 28654643 
  20. Rosset F, Celoria V, Delmonte S, Mastorino L, Sciamarrelli N, Boskovic S, et al. The Epidemiology of syphilis worldwide in the last decade. J Clin Med. 2025;14(15):5308.  https://doi.org/10.3390/jcm14155308  PMID: 40806930 
  21. Hald SV, Hauge E. [Syphilis as a cause of intrauterine fetal death]. Ugeskr Læger. 2025;187(2):V09240632. Danish.  https://doi.org/10.61409/V09240632  PMID: 39917890 
/content/10.2807/1560-7917.ES.2026.31.35.2600031
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error